Systematic review investigating the reporting of comorbidities and medication in randomized controlled trials of people with dementia

Toby Smith; Ian Maidment; Jennifer Hebding; Tairo Madzima; Francine Cheater; Jane Cross; Fiona Poland; Jacqueline White; John Young; Chris Fox

doi:10.1093/ageing/afu100

Systematic review investigating the reporting of comorbidities and medication in randomized controlled trials of people with dementia

Toby Smith
, Ian Maidment
, Jennifer Hebding
, Tairo Madzima
, Francine Cheater
, Jane Cross
, Fiona Poland
, Jacqueline White
, John Young
, Chris Fox

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Abstract

Dementia is a debilitating condition characterised by global loss of cognitive and intellectual functioning, which reduces social and occupational performance. This population frequently presents with medical co-morbidities such as hypertension, cardiovascular disease and diabetes. The CONSORT statement outlines recommended guidance on reporting of participant characteristics in clinical trials. It is, however, unclear how much these are adhered to in trials assessing people with dementia. This paper assesses the reporting of medical co-morbidities and prescribed medications for people with dementia within randomised controlled trial (RCT) reports.

Original language	English
Pages (from-to)	868-872
Number of pages	5
Journal	Age and Ageing
Volume	43
Issue number	6
Early online date	19 Oct 2014
DOIs	https://doi.org/10.1093/ageing/afu100
Publication status	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

cognitive impairment
dementia
co-morbidity
older people
systematic review

Access to Document

10.1093/ageing/afu100

Jane Cross
- J.Crossuea.acuk
- Dementia & Complexity in Later Life - Member
- Norwich Medical School - Director of Norwich Clinical Trials Unit
- School of Health Sciences - Professor
- Mental Health and Social Care - Member
- Public Health - Member
- Volunteering and Health and Social Care - Member
- HealthUEA - Steering Committee Member
Person: Research Group Member, Research Centre Member, Academic, Teaching and Research
Chris Fox
- Chris.Foxuea.acuk
- Norwich Medical School - Honorary Professor
- Institute for Volunteering Research - Member
- Norwich Epidemiology Centre - Member
- Mental Health - Member
Person: Honorary, Research Group Member, Research Centre Member
Fiona Poland
- F.Polanduea.acuk
- School of Health Sciences - Professor of Social Research Methodology
- Norwich Institute for Healthy Aging - Member
- Institute for Volunteering Research - Member
- Mental Health and Social Care - Member
- Volunteering and Health and Social Care - Group Lead
- Critical Volunteering Studies - Member
- Dementia & Complexity in Later Life - Member
Person: Group Lead, Research Group Member, Research Centre Member, Academic, Teaching and Research

Cite this

@article{e36db1a4736847da90997c005102ac17,

title = "Systematic review investigating the reporting of comorbidities and medication in randomized controlled trials of people with dementia",

abstract = "Dementia is a debilitating condition characterised by global loss of cognitive and intellectual functioning, which reduces social and occupational performance. This population frequently presents with medical co-morbidities such as hypertension, cardiovascular disease and diabetes. The CONSORT statement outlines recommended guidance on reporting of participant characteristics in clinical trials. It is, however, unclear how much these are adhered to in trials assessing people with dementia. This paper assesses the reporting of medical co-morbidities and prescribed medications for people with dementia within randomised controlled trial (RCT) reports.",

keywords = "cognitive impairment, dementia, co-morbidity, older people, systematic review",

author = "Toby Smith and Ian Maidment and Jennifer Hebding and Tairo Madzima and Francine Cheater and Jane Cross and Fiona Poland and Jacqueline White and John Young and Chris Fox",

year = "2014",

doi = "10.1093/ageing/afu100",

language = "English",

volume = "43",

pages = "868--872",

journal = "Age and Ageing",

issn = "0002-0729",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Systematic review investigating the reporting of comorbidities and medication in randomized controlled trials of people with dementia

AU - Smith, Toby

AU - Maidment, Ian

AU - Hebding, Jennifer

AU - Madzima, Tairo

AU - Cheater, Francine

AU - Cross, Jane

AU - Poland, Fiona

AU - White, Jacqueline

AU - Young, John

AU - Fox, Chris

PY - 2014

Y1 - 2014

N2 - Dementia is a debilitating condition characterised by global loss of cognitive and intellectual functioning, which reduces social and occupational performance. This population frequently presents with medical co-morbidities such as hypertension, cardiovascular disease and diabetes. The CONSORT statement outlines recommended guidance on reporting of participant characteristics in clinical trials. It is, however, unclear how much these are adhered to in trials assessing people with dementia. This paper assesses the reporting of medical co-morbidities and prescribed medications for people with dementia within randomised controlled trial (RCT) reports.

AB - Dementia is a debilitating condition characterised by global loss of cognitive and intellectual functioning, which reduces social and occupational performance. This population frequently presents with medical co-morbidities such as hypertension, cardiovascular disease and diabetes. The CONSORT statement outlines recommended guidance on reporting of participant characteristics in clinical trials. It is, however, unclear how much these are adhered to in trials assessing people with dementia. This paper assesses the reporting of medical co-morbidities and prescribed medications for people with dementia within randomised controlled trial (RCT) reports.

KW - cognitive impairment

KW - dementia

KW - co-morbidity

KW - older people

KW - systematic review

U2 - 10.1093/ageing/afu100

DO - 10.1093/ageing/afu100

M3 - Article

C2 - 25038835

SN - 0002-0729

VL - 43

SP - 868

EP - 872

JO - Age and Ageing

JF - Age and Ageing

IS - 6

ER -

Systematic review investigating the reporting of comorbidities and medication in randomized controlled trials of people with dementia

Abstract

UN SDGs

Keywords

Access to Document

Profiles

Jane Cross

Chris Fox

Fiona Poland

Cite this